Consumer Health companies face unchartered waters due to hugely disruptive global trade environment. This follows a period of positive, if not always smooth, performance. The long-term trends of moving away from treatment to prevention has ensured gradual, broad-based increase of sales over the period of 2019 to 2024. In 2025, industry’s top leaders are focused on the search for efficiencies, be it by divesting their worst-performing brands or leveraging newly emerging technologies.
This report comes in PPT.
Consumer health companies continue to benefit from longer-standing trends such as the move from treatment to prevention, rising interest in sports nutrition and the adoption of holistic approaches to health. Newly emerging trends, such as healthy ageing and the new generation of weight loss drugs, will likely shape the market positively, presenting companies with ripe market opportunities. At the same time, consumer health companies face challenges from FMCG incumbents as they more aggressively promote healthier versions of their offerings, further blurring the lines of health and nutrition.
Industry leaders are prioritising their core brands and are divesting long-tail products that fail to deliver sales targets or do not match the leaner, more focused, vision of the companies. For their core portfolios, consumer health firms are eyeing collaboration, such as partnerships with tech/data companies, understanding that they cannot do it all alone; that said, personalised and subscription-based offerings by itself are not enough to attract new consumers.
The ascendance of technologies continues. Traditional products are increasingly accompanied by or paired with mobile apps to track the products’ progress/efficacy. The nature of selling is changing too, with social media emerging as a go-to channel for information, something health professionals and influencers leverage to their advantage. Newer media such as podcasts also shape these trends, with content around trends such as longevity proving popular.
Global consumer health players will be affected by unpredictable trade policies in the near to mid term. This likely means delay of projects, fewer M&A activities and the reorganisation of manufacturing processes. Disruption to supply chains echoing those during the COVID era will be likely, necessitating the need for companies to stay agile.
It is the aggregation of OTC, Vitamins and Dietary Supplements (VDS), Sports Nutrition, and Weight Management and Wellbeing
See all of our definitionsIf you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!